0001192482-19-000220.txt : 20190429 0001192482-19-000220.hdr.sgml : 20190429 20190429185219 ACCESSION NUMBER: 0001192482-19-000220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190425 FILED AS OF DATE: 20190429 DATE AS OF CHANGE: 20190429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schroeder Theodore R CENTRAL INDEX KEY: 0001378690 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37372 FILM NUMBER: 19777739 MAIL ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC CENTRAL INDEX KEY: 0001267565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 BUSINESS PHONE: 781-713-3699 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 FORMER COMPANY: FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC DATE OF NAME CHANGE: 20031020 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-04-25 0001267565 COLLEGIUM PHARMACEUTICAL, INC COLL 0001378690 Schroeder Theodore R C/O COLLEGIUM PHARMACEUTICAL, INC. 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 1 0 0 0 Common Stock 2019-04-25 4 A 0 4707 0 A 6960 D Stock Option (Right to Purchase) 14.57 2019-04-25 4 A 0 9414 0 A 2029-04-25 Common Stock 9414 9414 D Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 25, 2020, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock. The option vests and becomes exercisable on April 25, 2020, subject to the director's continued service with the issuer. /s/ Paul Brannelly as Attorney-In-Fact For Theodore R. Schroeder 2019-04-29